Russell Investments Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.5M | Buy |
145,533
+10,168
| +8% | +$1.16M | 0.02% | 647 |
|
2025
Q1 | $14.2M | Buy |
135,365
+39,765
| +42% | +$4.18M | 0.02% | 690 |
|
2024
Q4 | $10.2M | Sell |
95,600
-20,654
| -18% | -$2.21M | 0.01% | 807 |
|
2024
Q3 | $11.6M | Buy |
116,254
+24,790
| +27% | +$2.48M | 0.02% | 774 |
|
2024
Q2 | $7.71M | Buy |
91,464
+18,303
| +25% | +$1.54M | 0.01% | 948 |
|
2024
Q1 | $5.35M | Buy |
73,161
+44,499
| +155% | +$3.25M | 0.01% | 1137 |
|
2023
Q4 | $2.05M | Buy |
28,662
+11,345
| +66% | +$810K | ﹤0.01% | 1603 |
|
2023
Q3 | $1.04M | Sell |
17,317
-30,777
| -64% | -$1.84M | ﹤0.01% | 1906 |
|
2023
Q2 | $3.47M | Sell |
48,094
-8,351
| -15% | -$602K | 0.01% | 1248 |
|
2023
Q1 | $4.15M | Buy |
56,445
+18,568
| +49% | +$1.37M | 0.01% | 1188 |
|
2022
Q4 | $2.53M | Buy |
37,877
+23,437
| +162% | +$1.57M | 0.01% | 1443 |
|
2022
Q3 | $775K | Hold |
14,440
| – | – | ﹤0.01% | 2051 |
|
2022
Q2 | $803K | Hold |
14,440
| – | – | ﹤0.01% | 2056 |
|
2022
Q1 | $1.01M | Sell |
14,440
-12,431
| -46% | -$872K | ﹤0.01% | 1957 |
|
2021
Q4 | $2.59M | Sell |
26,871
-2,425
| -8% | -$233K | ﹤0.01% | 1660 |
|
2021
Q3 | $2.55M | Sell |
29,296
-3,088
| -10% | -$268K | ﹤0.01% | 1690 |
|
2021
Q2 | $2.65M | Sell |
32,384
-12,377
| -28% | -$1.01M | ﹤0.01% | 1747 |
|
2021
Q1 | $4.26M | Sell |
44,761
-179,189
| -80% | -$17M | 0.01% | 1444 |
|
2020
Q4 | $13.9M | Sell |
223,950
-41,074
| -15% | -$2.55M | 0.03% | 670 |
|
2020
Q3 | $15.8M | Buy |
265,024
+31,103
| +13% | +$1.85M | 0.03% | 569 |
|
2020
Q2 | $16.3M | Sell |
233,921
-20,281
| -8% | -$1.41M | 0.04% | 535 |
|
2020
Q1 | $11.5M | Buy |
254,202
+29,090
| +13% | +$1.32M | 0.03% | 596 |
|
2019
Q4 | $14.6M | Buy |
225,112
+8,819
| +4% | +$574K | 0.03% | 677 |
|
2019
Q3 | $13.4M | Sell |
216,293
-28,631
| -12% | -$1.78M | 0.03% | 714 |
|
2019
Q2 | $17.4M | Buy |
244,924
+8,275
| +3% | +$589K | 0.03% | 617 |
|
2019
Q1 | $18.6M | Sell |
236,649
-48,318
| -17% | -$3.79M | 0.03% | 605 |
|
2018
Q4 | $24.1M | Buy |
284,967
+37,805
| +15% | +$3.2M | 0.05% | 411 |
|
2018
Q3 | $42.3M | Sell |
247,162
-63,150
| -20% | -$10.8M | 0.08% | 271 |
|
2018
Q2 | $40.1M | Sell |
310,312
-111,925
| -27% | -$14.5M | 0.08% | 261 |
|
2018
Q1 | $43.5M | Sell |
422,237
-111,950
| -21% | -$11.5M | 0.07% | 319 |
|
2017
Q4 | $46.2M | Sell |
534,187
-36,077
| -6% | -$3.12M | 0.08% | 308 |
|
2017
Q3 | $48.4M | Sell |
570,264
-26,797
| -4% | -$2.28M | 0.08% | 289 |
|
2017
Q2 | $45.2M | Buy |
597,061
+164,935
| +38% | +$12.5M | 0.08% | 307 |
|
2017
Q1 | $28.5M | Sell |
432,126
-15,618
| -3% | -$1.03M | 0.05% | 435 |
|
2016
Q4 | $28.4M | Buy |
+447,744
| New | +$28.4M | 0.06% | 423 |
|